Health Condition 1: N51- Disorders of male genital organs in diseases classified elsewhere Health Condition 2: H260- Infantile and juvenile cataract Health Condition 3: C692- Malignant neoplasm of retina Health Condition 4: K358- Other and unspecified acute appendicitis Health Condition 5: Q321- Other congenital malformations oftrachea Health Condition 6: K638- Other specified diseases of intestine Health Condition 7: N288- Other specified disorders of kidney and ureter Health Condition 8: R098-
Conditions
Interventions
Intervention1: Group B - 39 patients, 3 microgram/kg dexmedetomidine mixed in normal saline to make a total volume of 3 ml.: Group B will receive nebulisation with dexmedetomidine at a dose 3mcg/kg di
Sponsors
Gauhati Medical College
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age group 1-8 years. 2.American Society of Anaesthesiologists physical status 1 or 2 3.Availability of informed consent. 4.Any gender
Exclusion criteria
Exclusion criteria: 1. Parents refusal. 2.Patients with history of cardiac disease,asthma,seizure disorders. 3.patients with mental retardation,developmental delay or any congenital anomalies. 4.Patients with known allergy to dexmedetomidine.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Parental seperation anxiety score and mask acceptance scoreTimepoint: 30 mins after beginning of nebulisation. | — |
Secondary
| Measure | Time frame |
|---|---|
| To access emergence agitation post operatively.Timepoint: Immediately after emergence;To access hemodynamic variables intraoperatively. Timepoint: 10 minutes interval introperatively;To access post operative sedation.Timepoint: 1 hour and 2 hours post operatively. | — |
Countries
India
Contacts
Public ContactDr Sanchita Sarma Borkataki
Gauhati Medical College
Outcome results
None listed